Martin Meeson  is a seasoned executive who brings extensive global experience to the Biotech and Pharmaceutical markets. In his current role as President and COO, he directs all aspects of the operations for the US sites with locations in RTP, North Carolina and College Station, Texas. Martin was named President and COO of the US operations on April 1st, 2015. Previously Martin served as Chief Financial Officer for the US. Prior to this, Martin worked for the Fujifilm Diosynth organization for over 6 years, holding leadership positions at the United Kingdom site, including Head of Finance and IT. Before joining Fujifilm Diosynth he was Finance director at Oxford Chemicals where he was responsible for all aspects of Finance, IT, and Purchasing. He has also held leadership positions at Hibernia Foods, ICI/Dupont and KPMG. Martin Meeson  is a seasoned executive who brings extensive global experience to the Biotech and Pharmaceutical markets. In his current role as President and COO, he directs all aspects of the operations for the US sites with locations in RTP, North Carolina and College Station, Texas. Martin was named President and COO of the US operations on April 1st, 2015. Previously Martin served as Chief Financial Officer for the US. Prior to this, Martin worked for the Fujifilm Diosynth organization for over 6 years, holding leadership positions at the United Kingdom site, including Head of Finance and IT. Before joining Fujifilm Diosynth he was Finance director at Oxford Chemicals where he was responsible for all aspects of Finance, IT, and Purchasing. He has also held leadership positions at Hibernia Foods, ICI/Dupont and KPMG.

fermentation